πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 750 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7314618

Antibodies to fibroblast growth factor (FGF23)

Ludwig-Maximilians-Universitat Munchen Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314631

Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect agains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7288671

Interleukin-1 and tumor necrosis factor-Ξ± modulators, synthesis of said modulators and the

The Regents of the University of California Β· Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7285542

Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7264947

Activity dependent neurotrophic factor III (ADNF III)

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7252989

Adenovirus supervector system

The Board of Regents of the University of Texas System Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7247707

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT Β· Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7241860

Transcription factor polypeptide that regulates Chondromodulin-I expression

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7223563

Fibroblast growth factor (FGF23) nucleic acids

Ludwig-Maximilians-Universitat Munchen Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7211432

Recombinant vector expressing multiple costimulatory molecules and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7211402

Transcription factor coactivator protein, p/CIP

The Regents of the University of California Β· Granted Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208313

Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7199223

Polymer-factor VIII moiety conjugates

Nektar Therapeutics AL, Corporation Β· Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7192593

Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection an

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7193075

Sequences upstream of the CARP gene, vectors containing them and uses thereof

The Regents of the University of California Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7193053

Hypoxia-inducible factor 1alpha variants and methods of use

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7192914

Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand fact

The Regents of the University of California Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7179621

Pigment epithelium-derived factor: sequence of the PEDF gene

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7160720

CHAMPβ€”a novel cardiac helicase-like factor

The Board of Regents of the University of Texas System Β· Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7160722

Master bone formation transcription factor: compositions and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7135303

Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7119066

Modified ciliary neurotrophic factor (CNTF)

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7119223

Interleukin-1 and tumor necrosis factor-Ξ± modulators, synthesis of said modulators and th

The Regents of the University of California Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7109245

Vasoconstrictor cannabinoid analogs

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted